SCHEMBL14274602

SCHEMBL14274602

CC(C)CCCCCCCCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(N)=O)C(=O)NC(CC(=O)O)C(=O)NC1C(=O)NCC(=O)NC(CCCN)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)OC1C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.74
▸ DRD1 P21728 1/20 0.74
▸ PTGS1 P23219 1/20 0.74
▸ PDE4A P27815 1/20 0.74
▸ F2 P00734 1/20 0.42
▸ TSLP Q969D9 2/20 0.41
▸ KEAP1 Q14145 2/20 0.41
▸ IL23R Q5VWK5 6/20 0.41
▸ KCNMA1 Q12791 1/20 0.41
▸ KCNMB4 Q86W47 1/20 0.41
▸ EPHA2 P29317 2/20 0.40
▸ CTSG P08311 1/20 0.40
▸ ITGB3 P05106 2/20 0.40
▸ ITGAV P06756 2/20 0.40
▸ ITGB1 P05556 1/20 0.39
▸ ITGA5 P08648 1/20 0.39
▸ ITGB6 P18564 1/20 0.39
▸ ITGB8 P26012 1/20 0.39
▸ MDM4 O15151 1/20 0.39
▸ MDM2 Q00987 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14274584 0.98 CTSL (0.77) CTSLDRD1PTGS1PDE4AF2
SCHEMBL14274597 0.97 CTSL (0.79) CTSLDRD1PTGS1PDE4AF2
SCHEMBL14274636 0.96 CTSL (0.74) CTSLDRD1PTGS1PDE4AF2
SCHEMBL14274734 0.96 CTSL (0.78) CTSLDRD1PTGS1PDE4AF2
SCHEMBL14274605 0.96 CTSL (0.74) CTSLDRD1PTGS1PDE4AF2
SCHEMBL14274612 0.96 CTSL (0.74) CTSLDRD1PTGS1PDE4AF2
SCHEMBL14274712 0.96 CTSL (0.74) CTSLDRD1PTGS1PDE4AF2
SCHEMBL14274604 0.96 CTSL (0.75) CTSLDRD1PTGS1PDE4AF2
SCHEMBL14274592 0.96 CTSL (0.73) CTSLDRD1PTGS1PDE4ATSLP
SCHEMBL14274571 0.95 CTSL (0.82) CTSLDRD1PTGS1PDE4AF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051326-A1 Antiinfective Lipopeptides CUBIST PHARMACEUTICALS, INC. 2008-02-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051326-A1 Antiinfective Lipopeptides VIP, NGLY1, PREP CTSL 49/4885DRD1 3359/4885PTGS1 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback